Research Index

VIP (Vasoactive Intestinal Peptide) Research Index

PSI surfaces 29 peer-reviewed studies on VIP (Vasoactive Intestinal Peptide), prioritized by evidence strength: human clinical research first, then animal studies. The full historical archive is linked below on PubMed.

Sort
Type
Condition

29 studies

A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.

Coutinho LFD, DE Oliveira Neves LF, Camilo RP

J Sports Med Phys Fitness·2026·Animal·PubMed →

Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.

Uçaktürk E, Nemutlu E

J Pharm Biomed Anal·2026·Animal·GH Activity·PubMed →

Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.

Mavrych V, Shypilova I, Bolgova O

Front Aging·2026·Review·PubMed →

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

Mendias CL, Awan TM

Sports Med·2026·Review·PubMed →

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Rahman OF, Lee SJ, Seeds WA

J Am Acad Orthop Surg Glob Res Rev·2026·Review·Wound Healing·PubMed →

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.

Mayfield CK, Bolia IK, Feingold CL et al.

Am J Sports Med·2026·Review·PubMed →

Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.

Thomas A, Walpurgis K, Thevis M

J Mass Spectrom·2024·Animal·GH Activity·PubMed →

Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.

Cristea CD, Radu M, Toboc A et al.

Anal Biochem·2023·Animal·PubMed →

Probing for peptidic drugs (2-10 kDa) in doping control blood samples.

Thomas A, Thilmany S, Hofmann A et al.

Anal Sci Adv·2022·Animal·PubMed →

An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.

Coppieters G, Deventer K, Polet M et al.

J Pharm Biomed Anal·2022·Animal·GH Activity·PubMed →

Early detection of cannabinoids in biological samples based on their affinity interaction with the growth hormone secretagogue receptor.

Danila GM, Puiu M, Zamfir LG et al.

Talanta·2022·Animal·PubMed →

Advances in the detection of growth hormone releasing hormone synthetic analogs.

Memdouh S, Gavrilović I, Ng K et al.

Drug Test Anal·2021·Animal·GH Activity·PubMed →

Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry.

Pont L, Alechaga É, Terrero A et al.

J Chromatogr A·2020·Animal·GH Activity·PubMed →

A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS.

Timms M, Ganio K, Steel R

Drug Test Anal·2019·Animal·GH Activity·PubMed →

An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma.

Timms M, Ganio K, Forbes G et al.

Drug Test Anal·2019·Animal·GH Activity·PubMed →

The study of doping market: How to produce intelligence from Internet forums.

Pineau T, Schopfer A, Grossrieder L et al.

Forensic Sci Int·2016·Animal·PubMed →

Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.

Knoop A, Thomas A, Fichant E et al.

Anal Bioanal Chem·2016·Animal·GH Activity·PubMed →

Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.

Van Hout MC, Hearne E

Subst Use Misuse·2016·Review·GH Activity·PubMed →

Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS.

Thomas A, Walpurgis K, Tretzel L et al.

Drug Test Anal·2015·Animal·PubMed →

Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.

Thevis M, Thomas A, Schänzer W

Expert Rev Proteomics·2014·Animal·PubMed →

Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.

Kwok WH, Ho EN, Lau MY et al.

Anal Bioanal Chem·2013·Animal·PubMed →

Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls.

Thomas A, Schänzer W, Delahaut P et al.

Methods·2012·Review·GH Activity·PubMed →

Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.

Henninge J, Pepaj M, Hullstein I et al.

Drug Test Anal·2010·Animal·GH Activity·PubMed →

Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.

Sackmann-Sala L, Ding J, Frohman LA et al.

Growth Horm IGF Res·2009·Animal·GH Activity·PubMed →

Neuronal M3 muscarinic acetylcholine receptors are essential for somatotroph proliferation and normal somatic growth.

Gautam D, Jeon J, Starost MF et al.

Proc Natl Acad Sci U S A·2009·Animal·Weight Loss, GH Activity·PubMed →

Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.

Ionescu M, Frohman LA

J Clin Endocrinol Metab·2006·Human·GH Activity·PubMed →

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

Teichman SL, Neale A, Lawrence B et al.

J Clin Endocrinol Metab·2006·Human·GH Activity·PubMed →

Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.

Alba M, Fintini D, Sagazio A et al.

Am J Physiol Endocrinol Metab·2006·Animal·Longevity, Weight Loss, GH Activity·PubMed →

Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.

Jetté L, Léger R, Thibaudeau K et al.

Endocrinology·2005·Animal·GH Activity·PubMed →